Home Newsfeeds Kronos Bio Q2 EPS $(0.59) Down From $(0.53) YoY

Kronos Bio Q2 EPS $(0.59) Down From $(0.53) YoY

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.

byBill Haddad

August 4, 2022

1 minute read

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.

Wells Fargo Maintains Equal-Weight on Werner Enterprises, Raises Price Target to $43

By Benzinga Newsdesk

July 15, 8:22 AM

Wells Fargo analyst Allison Poliniak Cusic maintains Werner Enterprises (NASDAQ:WERN) with a Equal-Weight and raises the price target from $38 to $43.

WERN

Why Are Mallinckrodt Shares Tumbling Today

By Vandana Singh

June 5, 11:05 AM

Mallinckrodt Plc (NYSE: MNK) is reportedly considering options, including filing for bankruptcy again as a $200 million opioid settlement payment is due within weeks.

MNK

News

Payoneer and Airbnb Expand Long-Term Relationship To Allow Hosts In Additional Countries To Get Paid In Local Currency

By Benzinga Newsdesk

September 19, 8:09 AM

Airbnb retains Payoneer as a preferred global payment provider for another three yearsPayoneer (NASDAQ:PAYO), the financial technology company empowering the world's small and medium-sized businesses to transact, do

ABNB